Govindan Rajivgandhi Selected Research

Urinary Tract Infections (Urinary Tract Infection)

1/2019	Biosynthesized silver nanoparticles for inhibition of antibacterial resistance and biofilm formation of methicillin-resistant coagulase negative Staphylococci.
8/2018	Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Govindan Rajivgandhi Research Topics

Disease

5	Lung Neoplasms (Lung Cancer) 07/2023 - 12/2018
4	Neoplasms (Cancer) 01/2021 - 09/2019
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 08/2018
1	Pneumonia (Pneumonitis) 02/2019
1	Infections 08/2018

Drug/Important Bio-Agent (IBA)

3	SilverIBA 07/2023 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2019 - 08/2018
1	IonsIBA 01/2021
1	Heavy MetalsIBA 01/2021
1	NickelIBA 01/2021
1	terpinoleneIBA 12/2020
1	indoleIBA 12/2020
1	nordamnacanthalIBA 12/2020
1	morindoneIBA 12/2020
1	Biocompatible Materials (Biomaterials)IBA 12/2020
1	Volatile Oils (Essential Oils)IBA 12/2020
1	ScopoletinIBA 12/2020
1	ChitosanIBA 12/2020
1	GraphiteIBA 09/2019
1	nickel monoxide (nickel oxide)IBA 09/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	CoagulaseIBA 01/2019
1	Colistin (Coly-Mycin)FDA Link 12/2018
1	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2018

Therapy/Procedure

1	Lasers (Laser) 01/2019